AMGN
Price:
$337.6
Market Cap:
$182.21B
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infectio...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1983-06-17
Stock Exchange
NASDAQ
Ticker
AMGN
According to Amgen Inc.’s latest financial reports and current stock price. The company's current ROE is 89.41%. This represents a change of 306.87% compared to the average of 21.98% of the last 4 quarters.
The mean historical ROE of Amgen Inc. over the last ten years is 79.25%. The current 89.41% ROE has changed 12.83% with respect to the historical average. Over the past ten years (40 quarters), AMGN's ROE was at its highest in in the March 2022 quarter at 161.14%. The ROE was at its lowest in in the December 2017 quarter at -16.89%.
Average
79.25%
Median
79.14%
Minimum
7.84%
Maximum
178.97%
Discovering the peaks and valleys of Amgen Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 756.48%
Maximum Annual ROE = 178.97%
Minimum Annual Increase = -69.67%
Minimum Annual ROE = 7.84%
| Year | ROE | Change |
|---|---|---|
| 2025 | 89.06% | 27.98% |
| 2024 | 69.59% | -35.43% |
| 2023 | 107.78% | -39.78% |
| 2022 | 178.97% | 103.48% |
| 2021 | 87.96% | 13.93% |
| 2020 | 77.20% | -4.77% |
| 2019 | 81.07% | 20.73% |
| 2018 | 67.15% | 756.48% |
| 2017 | 7.84% | -69.67% |
| 2016 | 25.85% | 4.61% |
The current ROE of Amgen Inc. (AMGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
88.81%
5-year avg
106.67%
10-year avg
79.25%
Amgen Inc.’s ROE is less than Gilead Sciences, Inc. (42.16%), less than Pfizer Inc. (8.37%), less than Sanofi (14.41%), less than Merck & Co., Inc. (17.93%), less than Danaher Corporation (7.06%), less than Bristol-Myers Squibb Company (39.05%), less than Novo Nordisk A/S (66.36%), less than Boston Scientific Corporation (14.82%), less than GSK plc (35.78%), less than Novartis AG (31.54%),
| Company | ROE | Market cap |
|---|---|---|
| 42.16% | $153.66B | |
| 8.37% | $143.74B | |
| 14.41% | $101.89B | |
| 17.93% | $281.24B | |
| 7.06% | $125.40B | |
| 39.05% | $110.27B | |
| 66.36% | $191.93B | |
| 14.82% | $67.32B | |
| 35.78% | $101.54B | |
| 31.54% | $280.64B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amgen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amgen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Amgen Inc.'s ROE?
How is the ROE calculated for Amgen Inc. (AMGN)?
What is the highest ROE for Amgen Inc. (AMGN)?
What is the 3-year average ROE for Amgen Inc. (AMGN)?
What is the 5-year average ROE for Amgen Inc. (AMGN)?
How does the current ROE for Amgen Inc. (AMGN) compare to its historical average?